When to Use Inotuzumab Ozogamicin for Adult ALL

When to Use Inotuzumab Ozogamicin for Adult ALL

Does adding Inotuzumab ozogamicin to frontline therapy improve survival for adults with B-ALL?Подробнее

Does adding Inotuzumab ozogamicin to frontline therapy improve survival for adults with B-ALL?

Phase II trial of inotuzumab ozogamicin to treat MRD+ B-ALLПодробнее

Phase II trial of inotuzumab ozogamicin to treat MRD+ B-ALL

The evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with ALLПодробнее

The evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with ALL

Dose-adjusted EPOCH plus inotuzumab ozogamicin for B-ALLПодробнее

Dose-adjusted EPOCH plus inotuzumab ozogamicin for B-ALL

Inotuzumab ozogamicin for MRD-positive B-ALLПодробнее

Inotuzumab ozogamicin for MRD-positive B-ALL

Improving adult ALL treatment: pediatric regimens & adding inotuzumabПодробнее

Improving adult ALL treatment: pediatric regimens & adding inotuzumab

Side-effects of inotuzumab ozogamicinПодробнее

Side-effects of inotuzumab ozogamicin

Inotuzumab Ozogamicin in Relapsed/Refractory B-Cell Acute Lymphoblastic LeukaemiaПодробнее

Inotuzumab Ozogamicin in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia